Kiji Therapeutics engineered MSCs + IL-10 and CXCR4 offer tighter targeting and greater potency for challenging inflammatory diseases.

The company has other studies underway or completed with its iPSC-derived Cymerus MSC therapy. A phase II for graft-versus-host-disease (GvHD) is underway, while a phase I trial into diabetic foot ...

However, the need for large-scale expansion to obtain MSC-EVs for clinical use can lead to senescence-related changes and loss of stem-like properties. In this scenario, induced pluripotent stem cell ...

LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and world leader in neutrophil immuno-therapies, today announces the appointment of Mark A. Exley, PhD as Chief Scientific ...

including MSC therapy, chondrocyte therapy, immune cell therapy (specifically CAR-T cell therapy for osteosarcoma), and iPSC therapy. This comparison enables a comprehensive evaluation of their ...

MSC World America, the newest ship from MSC Cruises, caters to U.S. travelers with new features like a sports bar and comedy club. The ship offers a variety of amenities, including numerous dining ...

It also partnered with Panasonic for automated iPSC cell manufacturing. With this new automated iPSC technology and its strong partnerships with Taiwanese CDMO companies, LumiSTAR is now able to ...

MSC World America's Cliffhanger swing ride lifts passengers 160 feet above the ocean. The ride costs $5 and has height and weight requirements. Other new onboard activities include an outdoor ...

Our opinions are our own. MSC Cruises, a major European cruise line, is expanding its U.S. presence with a new ship. On April 9, 2025, the MSC World America set sail on its inaugural trip from ...